STANDARD BIOTOOLS INC. Income Statement
LAB|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
STANDARD BIOTOOLS INC. reported $106M in revenue and $75M in net loss for FY2025. Revenue has grown at a 10.8% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106.3M | $97.9M | $97.9M | $130.6M | $117.2M | $113.0M | $101.9M | $104.4M | $114.7M | $116.5M | $71.2M | $52.3M | $42.9M | $33.6M | $25.4M |
| Cost of Revenue | $55.9M | $60.9M | $60.9M | - | - | - | $50.0M | $46.0M | $43.0M | $300.0K | $300.0K | $300.0K | $100.0K | $100.0K | $11.5M |
| Gross Profit | $50.5M | $37.1M | $37.1M | - | - | - | $52.0M | $58.4M | - | - | - | - | - | - | - |
| SG&A Expense | $87.5M | $102.3M | $102.3M | $98.9M | $84.5M | $79.8M | $79.5M | $93.2M | $83.0M | $71.3M | $48.4M | $38.5M | $31.3M | $23.5M | $19.6M |
| R&D Expense | $25.9M | $37.4M | $37.4M | $37.9M | $31.6M | $30.0M | $30.8M | $38.4M | $39.3M | $43.4M | $20.0M | $16.6M | $13.9M | $25.0K | $12.3M |
| Operating Income | -$76.6M | -$116.2M | -$116.2M | -$67.5M | -$51.8M | -$48.2M | -$58.4M | -$73.2M | -$50.2M | -$51.8M | -$18.7M | -$18.1M | -$18.6M | -$14.6M | -$18.0M |
| Interest Expense | - | - | $4.3M | $3.8M | $4.3M | $13.9M | $5.8M | $5.8M | $5.8M | $5.3M | $14.0K | $628.0K | $3.1M | $2.2M | $2.9M |
| Income Tax | $452.0K | -$2.8M | -$2.8M | -$4.4M | -$1.9M | -$2.4M | -$3.3M | -$4.2M | -$1.5M | -$4.9M | $137.0K | $136.0K | $166.0K | $83.0K | -$50.0K |
| Net Income | -$74.7M | -$190.1M | -$190.1M | -$59.2M | -$64.8M | -$59.0M | -$60.5M | -$76.0M | -$53.3M | -$52.8M | -$16.5M | -$19.0M | -$22.5M | -$16.9M | -$19.1M |
| EPS (Basic) | -$0.94 | -$2.43 | -$2.43 | -$0.78 | -$0.97 | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$0.94 | -$2.43 | -$2.43 | -$0.78 | -$0.97 | -$1.49 | -$1.84 | -$2.62 | -$1.86 | -$1.90 | -$0.65 | -$0.86 | -$1.81 | -$8.94 | -$11.02 |
| Shares Outstanding | 377.5M | 80.2M | 79.5M | 76.9M | 74.5M | 70.0M | 49.3M | 38.8M | 29.2M | 28.8M | 28.3M | 25.8M | 25.1M | 20.3M | 1.9M |
| Gross Margin | 47.4% | 37.8% | 37.8% | - | - | - | 51.0% | 56.0% | - | - | - | - | - | - | - |
| Operating Margin | -72.0% | -118.6% | -118.6% | -51.7% | -44.2% | -42.6% | -57.3% | -70.1% | -43.7% | -44.5% | -26.2% | -34.5% | -43.3% | -43.4% | -71.0% |
| Profit Margin | -70.2% | -194.1% | -194.1% | -45.4% | -55.3% | -52.2% | -59.4% | -72.8% | -46.5% | -45.4% | -23.2% | -36.4% | -52.4% | -50.4% | -75.3% |